Cargando…

Implementing an electronic medication overview in Belgium

BACKGROUND: An accurate medication overview is essential to reduce medication errors. Therefore, it is essential to keep the medication overview up-to-date and to exchange healthcare information between healthcare professionals and patients. Digitally shared information yields possibilities to impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Storms, Hannelore, Marquet, Kristel, Nelissen, Katherine, Hulshagen, Leen, Lenie, Jan, Remmen, Roy, Claes, Neree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301824/
https://www.ncbi.nlm.nih.gov/pubmed/25516258
http://dx.doi.org/10.1186/1756-0500-7-915
_version_ 1782353697433452544
author Storms, Hannelore
Marquet, Kristel
Nelissen, Katherine
Hulshagen, Leen
Lenie, Jan
Remmen, Roy
Claes, Neree
author_facet Storms, Hannelore
Marquet, Kristel
Nelissen, Katherine
Hulshagen, Leen
Lenie, Jan
Remmen, Roy
Claes, Neree
author_sort Storms, Hannelore
collection PubMed
description BACKGROUND: An accurate medication overview is essential to reduce medication errors. Therefore, it is essential to keep the medication overview up-to-date and to exchange healthcare information between healthcare professionals and patients. Digitally shared information yields possibilities to improve communication. However, implementing a digitally shared medication overview is challenging. This articles describes the development process of a secured, electronic platform designed for exchanging medication information as executed in a pilot study in Belgium, called “Vitalink”. FINDINGS: The goal of “Vitalink” is to improve the exchange of medication information between professionals working in healthcare and patients in order to achieve a more efficient cooperation and better quality of care. Healthcare professionals of primary and secondary health care and patients of four Belgian regions participated in the project. In each region project groups coordinated implementation and reported back to the steering committee supervising the pilot study. The electronic medication overview was developed based on consensus in the project groups. The steering committee agreed to establish secured and authorized access through the use of electronic identity documents (eID) and a secured, eHealth-platform conform prior governmental regulations regarding privacy and security of healthcare information. DISCUSSION: A successful implementation of an electronic medication overview strongly depends on the accessibility and usability of the tool for healthcare professionals. Coordinating teams of the project groups concluded, based on their own observations and on problems reported to them, that secured and quick access to medical data needed to be pursued. According to their observations, the identification process using the eHealth platform, crucial to ensure secured data, was very time consuming. Secondly, software packages should meet the needs of their users, thus be adapted to daily activities of healthcare professionals. Moreover, software should be easy to install and run properly. The project would have benefited from a cost analysis executed by the national bodies prior to implementation.
format Online
Article
Text
id pubmed-4301824
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43018242015-01-22 Implementing an electronic medication overview in Belgium Storms, Hannelore Marquet, Kristel Nelissen, Katherine Hulshagen, Leen Lenie, Jan Remmen, Roy Claes, Neree BMC Res Notes Project Note BACKGROUND: An accurate medication overview is essential to reduce medication errors. Therefore, it is essential to keep the medication overview up-to-date and to exchange healthcare information between healthcare professionals and patients. Digitally shared information yields possibilities to improve communication. However, implementing a digitally shared medication overview is challenging. This articles describes the development process of a secured, electronic platform designed for exchanging medication information as executed in a pilot study in Belgium, called “Vitalink”. FINDINGS: The goal of “Vitalink” is to improve the exchange of medication information between professionals working in healthcare and patients in order to achieve a more efficient cooperation and better quality of care. Healthcare professionals of primary and secondary health care and patients of four Belgian regions participated in the project. In each region project groups coordinated implementation and reported back to the steering committee supervising the pilot study. The electronic medication overview was developed based on consensus in the project groups. The steering committee agreed to establish secured and authorized access through the use of electronic identity documents (eID) and a secured, eHealth-platform conform prior governmental regulations regarding privacy and security of healthcare information. DISCUSSION: A successful implementation of an electronic medication overview strongly depends on the accessibility and usability of the tool for healthcare professionals. Coordinating teams of the project groups concluded, based on their own observations and on problems reported to them, that secured and quick access to medical data needed to be pursued. According to their observations, the identification process using the eHealth platform, crucial to ensure secured data, was very time consuming. Secondly, software packages should meet the needs of their users, thus be adapted to daily activities of healthcare professionals. Moreover, software should be easy to install and run properly. The project would have benefited from a cost analysis executed by the national bodies prior to implementation. BioMed Central 2014-12-16 /pmc/articles/PMC4301824/ /pubmed/25516258 http://dx.doi.org/10.1186/1756-0500-7-915 Text en © Storms et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Project Note
Storms, Hannelore
Marquet, Kristel
Nelissen, Katherine
Hulshagen, Leen
Lenie, Jan
Remmen, Roy
Claes, Neree
Implementing an electronic medication overview in Belgium
title Implementing an electronic medication overview in Belgium
title_full Implementing an electronic medication overview in Belgium
title_fullStr Implementing an electronic medication overview in Belgium
title_full_unstemmed Implementing an electronic medication overview in Belgium
title_short Implementing an electronic medication overview in Belgium
title_sort implementing an electronic medication overview in belgium
topic Project Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301824/
https://www.ncbi.nlm.nih.gov/pubmed/25516258
http://dx.doi.org/10.1186/1756-0500-7-915
work_keys_str_mv AT stormshannelore implementinganelectronicmedicationoverviewinbelgium
AT marquetkristel implementinganelectronicmedicationoverviewinbelgium
AT nelissenkatherine implementinganelectronicmedicationoverviewinbelgium
AT hulshagenleen implementinganelectronicmedicationoverviewinbelgium
AT leniejan implementinganelectronicmedicationoverviewinbelgium
AT remmenroy implementinganelectronicmedicationoverviewinbelgium
AT claesneree implementinganelectronicmedicationoverviewinbelgium